(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
People mailed a free stool test kit are three times more likely to undergo colon cancer screening About 30% of patients sent a free kit completed their screening within six months By comparison ...
Here are 11 studies, developments and legislative moves that changed the colonoscopy landscape in 2024: 1. AI-assisted colonoscopies are associated with high detection and removal rates of ...
The test leverages polymerase chain reaction (PCR) technology to detect cancerous DNA in stool ... regular screening starting at age 45. "Mainz Biomed partners with Quest for colorectal cancer ...
Colorectal cancer (CRC) is the third most common cancer globally, with more than 1.9 million new cases reported in 2020, according to World Cancer Research Fund. The US Preventive Services Task Force ...
With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early. “If we find it early, we have a lot more options in treating it,” said Dr.